Developer docs
API playgroundTry for free, no card

Search company profiles

Advaita

Full company profile

uuid0003hwr

Namestring
Advaita
Legal namestring
Advaita Corporation
Websiteurl
advaitabio.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Advaita is described as a private bioinformatics company founded in 2006/2007 and headquartered in Ann Arbor, Michigan, with 11-50 employees. It serves academic and life-science researchers through pathway-analysis and multi-omics software, including iPathwayGuide, iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase. Its commercial model combines a $287 single-analysis purchase, subscriptions, institutional offerings, and a free iBioGuide, with an API also identified for batch processing.

The input describes iPathwayGuide as the flagship product, a weekly-updated knowledge base integrating 20+ databases, and iSCanGuide as a single-cell and spatial offering supported by GPU-accelerated infrastructure. It reports 13,000+ registered users, 19,900+ citations, and 800+ publications. The material also lists approximately $1.2 million in NSF grants across 2017, 2019, and 2020 and says no VC/PE funding is disclosed. No WX source identifier appears in the input, so these statements are unverified in this extraction.

Short descriptiontext

Advaita provides pathway-analysis and multi-omics software for academic and life-science researchers, offering flagship iPathwayGuide, single-cell and spatial iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase through subscriptions, institutional access, and per-analysis pricing options.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAnn Arbor, United States
HQ citystring
Ann Arbor
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioinformatics software platforms, multi-omics pathway analysis, single-cell transcriptomics analysis, variant interpretation software, omics data analytics
Industry5 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAF
Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
NAICS code2 codes
  • Software Publishers5132
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Bioinformatics Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1iPathwayGuide Subscriptions
TypeSubscription Recurring
Description

Subscription-based access to platform with per-user and volume-based pricing. Includes unlimited analyses at fixed cost. Annual and multi-year contract options available for academic and enterprise customers.

advaitabio.com
2Single Analysis Purchase
TypeOne Time License
Description

One-time purchase of individual analyses at USD 287 per analysis (as of June 2019). Suitable for researchers with occasional analysis needs.

advaitabio.com
3Departmental/Institution-wide Licenses
TypeSubscription Recurring
Description

Volume-based pricing scales with number of users and volume of analyses. Contact sales for enterprise-wide deployment options.

advaitabio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details4 tiers
1Single Analysis
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

USD 287 per analysis as of June 2019. Includes full interactive report, PDF report for publications, and sharing with collaborators at no extra cost.

advaitabio.com
2Subscription (Annual)
ModelSubscriptionBilling cadenceAnnual
Notes

Unlimited analyses at fixed cost. Pricing scales with number of users and volume of analyses. Contact sales team for quote.

advaitabio.com
3Free Tier (iBioGuide)
ModelFreemiumBilling cadenceMonthly
Notes

iBioGuide is 100% free. No email address required.

advaitabio.com
4Departmental/Institution-wide
ModelSubscriptionBilling cadenceAnnual
Notes

Volume-based pricing scales with users and volume. Contact team for institutional pricing.

advaitabio.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1iPathwayGuide
Description

Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for pathway analysis, gene ontology analysis, disease analysis, and upstream regulator analysis.

advaitabio.com
+4 more records
Core offering1 text field

Advaita develops and operates cloud-based bioinformatics analysis platforms that transform multi-omics, single-cell, and spatial transcriptomics datasets into biologically meaningful interpretations. Its flagship products are iPathwayGuide (multi-omics pathway and systems analysis using proprietary Impact Analysis methodology) and iSCanGuide (GPU-accelerated single-cell and spatial transcriptomics analysis), complemented by iBioGuide (free search tool), iVariantGuide (variant interpretation), and iKnowledgeBase (curated research databases). The platforms serve academic researchers, core facilities, CROs, and biotech/pharmaceutical enterprise teams with subscription and per-analysis pricing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Analysis completed in ~15 minutes versus potentially days of manual work
+2 more records
Product overview1 text field

Advaita Bio offers a bioinformatics platform suite centered on two flagship products: iPathwayGuide™ for multi-omics pathway and systems analysis using proprietary Impact Analysis, and iSCanGuide™ for GPU-accelerated single-cell and spatial transcriptomics. The platform is augmented by complementary tools including iBioGuide (free search engine), iVariantGuide (variant interpretation), and iKnowledgeBase (curated database). The architecture integrates these tools—iSCanGuide connects to iPathwayGuide to extend analysis from raw transcriptomics to biological interpretation—unified through cloud-based delivery requiring no local installation.

Product and service5 records
1iPathwayGuide
CategoryMulti-omics pathway analysis platform
Description

Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for transcriptomics, proteomics, epigenomics, and methylomics data interpretation. Supports human, mouse, and rat organisms and provides gene ontology analysis, pathway analysis, predicted miRNA analysis, disease analysis, and drug response predictions. Used by academic researchers, core facilities, and pharma research teams.

2iSCanGuide
CategorySingle-cell and spatial transcriptomics analysis platform
Description

GPU-optimized cloud platform for large-scale single-cell and spatial transcriptomics analysis with no-code GUI interface, standardized reproducible workflows, support for 10x Genomics Visium and Xenium formats, and integrated cell-to-cell communication analysis. Designed for researchers working with high-throughput single-cell and spatial datasets.

3iBioGuide
CategoryBiological search engine
Description

Free browser-based search tool built on Advaita's knowledge base of over 100 million biological relationships. Allows users to search for genes, microRNAs, pathways, biological processes, molecular functions, cellular components, drugs, diseases, and references. No email required to use.

4iVariantGuide
CategoryVariant interpretation platform
Description

Variant analysis and interpretation platform that takes VCF files, annotates them with multiple sources, and provides interactive filters for exploring relationships between biological features and effects. Includes advanced pruning algorithms for eliminating false positives in GO analysis. Accessible via API for batch processing.

5iKnowledgeBase
CategoryBiological knowledge database
Description

Curated research knowledge base containing integrated databases for genes, pathways, diseases, drugs, microRNAs, GO terms, and molecular interactions, updated weekly with 20+ integrated sources plus a proprietary layer.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-10-14
Description

Distribution partnership providing advanced pathway analysis software access to researchers in Sub-Saharan Africa. Inqaba Biotechnical Industries serves as the authorized distributor for the region.

2SCIEX
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration enabling users to bring SWATH proteomics data from SCIEX workflow and analyze it in the context of pathways, gene ontologies, microRNAs, and diseases within iPathwayGuide. Combines protein expression experiments with RNA-Seq, microarrays, and targeted panels.

advaitabio.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic origin of the technology. Dr. Sorin Draghici developed the Impact Analysis method at Wayne State University's Intelligent Systems and Bioinformatics Laboratory. Ongoing academic affiliation with Dr. Draghici serving as Professor of Computer Science and Obstetrics and Gynecology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Sorin Draghici serves as Program Director at NSF since July 2022. Represents academic-government partnership and scientific credibility.

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

QIAGEN's Ingenuity Pathway Analysis (IPA) is the most entrenched commercial pathway and multi-omics interpretation platform, directly competing with iPathwayGuide across transcriptomics, proteomics, and upstream regulator analysis for both academic and pharma customers.

TypeDirect peer
Description

Illumina acquired Partek, a genomics/bioinformatics software suite offering pathway and single-cell analysis — a direct competitor in cloud-based omics interpretation, now backed by Illumina's sequencing installed base.

TypeDirect peer
Description

Velsera operates a cloud bioinformatics platform for multi-omics and single-cell analysis with API-accessible workflows, directly comparable to Advaita's cloud-delivered, no-code analysis positioning for cores, CROs, and enterprise teams.

TypeDirect peer
Description

DNAnexus provides a regulated (HIPAA/FedRAMP) cloud bioinformatics platform for omics data processing and analysis, competing with Advaita for translational and pharma enterprise workloads that require compliant, programmatic, multi-omics pipelines.

TypeEmerging player
Description

GSEA and the MSigDB molecular signature database are the de facto open-standard pathway and enrichment analysis tooling, competing head-on with iPathwayGuide's enrichment analysis layer and influencing academic purchasing decisions.

TypeBroad incumbent
Description

Benchling is a broader cloud R&D platform for life sciences that includes registry, assay, and increasingly informatics workflows — an incumbent adjacent to Advaita that competes for biotech enterprise IT budgets and could expand into omics interpretation.

TypeBroad incumbent
Description

10x Genomics bundles proprietary single-cell and spatial analysis software with its instruments; its cloud analysis offerings directly overlap with iSCanGuide for Visium and Xenium users, and 10x's installed base gives it a structural advantage.

TypeBroad incumbent
Description

Dotmatics provides an end-to-end scientific R&D platform spanning informatics, biology, and chemistry; its biology and omics modules overlap with Advaita's pathway and multi-omics interpretation positioning for pharma R&D.

TypeEmerging player
Description

Rosalind offers a cloud-based, no-code bioinformatics platform with single-cell and pathway analysis capabilities, competing with iSCanGuide/iPathwayGuide in the no-code, multi-omics experience for academic and translational researchers.

10Metascape
TypeEmerging player
Description

Metascape is a widely adopted free academic pathway analysis tool with multi-omics support; it competes with iPathwayGuide for academic PIs who might otherwise adopt a paid commercial alternative if pricing pressure exists.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Advaita

Bioinformatics Softwareadvaitabio.com

Advaita provides pathway-analysis and multi-omics software for academic and life-science researchers, offering flagship iPathwayGuide, single-cell and spatial iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase through subscriptions, institutional access, and per-analysis pricing options.

What Advaita does

Advaita is described as a private bioinformatics company founded in 2006/2007 and headquartered in Ann Arbor, Michigan, with 11-50 employees. It serves academic and life-science researchers through pathway-analysis and multi-omics software, including iPathwayGuide, iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase. Its commercial model combines a $287 single-analysis purchase, subscriptions, institutional offerings, and a free iBioGuide, with an API also identified for batch processing.

The input describes iPathwayGuide as the flagship product, a weekly-updated knowledge base integrating 20+ databases, and iSCanGuide as a single-cell and spatial offering supported by GPU-accelerated infrastructure. It reports 13,000+ registered users, 19,900+ citations, and 800+ publications. The material also lists approximately $1.2 million in NSF grants across 2017, 2019, and 2020 and says no VC/PE funding is disclosed. No WX source identifier appears in the input, so these statements are unverified in this extraction.

Advaita firmographics

Firmographics
Name
Advaita
Legal name
Advaita Corporation
Website
https://advaitabio.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Advaita provides pathway-analysis and multi-omics software for academic and life-science researchers, offering flagship iPathwayGuide, single-cell and spatial iSCanGuide, iBioGuide, iVariantGuide, and iKnowledgeBase through subscriptions, institutional access, and per-analysis pricing options.
Ownership category
akta.pro rank

Advaita industry classification

Industry
Product category
Bioinformatics Software
NAICS
Software Publishers (5132), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAIAF
Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAIAI
Target Identification & Validation Platforms (omics-driven, chemoproteomics, genetic validation)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

  • Bioinformatics software platforms
  • Multi-omics pathway analysis
  • Single-cell transcriptomics analysis
  • Variant interpretation software
  • Omics data analytics

Where Advaita is headquartered

Location

Headquarters

HQ city
Ann Arbor
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Advaita business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. iPathwayGuide Subscriptions: Subscription-based access to platform with per-user and volume-based pricing. Includes unlimited analyses at fixed cost. Annual and multi-year contract options available for academic and enterprise customers.
  2. Single Analysis Purchase: One-time purchase of individual analyses at USD 287 per analysis (as of June 2019). Suitable for researchers with occasional analysis needs.
  3. Departmental/Institution-wide Licenses: Volume-based pricing scales with number of users and volume of analyses. Contact sales for enterprise-wide deployment options.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goSingle Analysis
SubscriptionAnnualSubscription (Annual)
FreemiumMonthlyFree Tier (iBioGuide)
SubscriptionAnnualDepartmental/Institution-wide

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Advaita product offering

Product offering

Core offering

Advaita develops and operates cloud-based bioinformatics analysis platforms that transform multi-omics, single-cell, and spatial transcriptomics datasets into biologically meaningful interpretations. Its flagship products are iPathwayGuide (multi-omics pathway and systems analysis using proprietary Impact Analysis methodology) and iSCanGuide (GPU-accelerated single-cell and spatial transcriptomics analysis), complemented by iBioGuide (free search tool), iVariantGuide (variant interpretation), and iKnowledgeBase (curated research databases). The platforms serve academic researchers, core facilities, CROs, and biotech/pharmaceutical enterprise teams with subscription and per-analysis pricing.

Product overview

Advaita Bio offers a bioinformatics platform suite centered on two flagship products: iPathwayGuide™ for multi-omics pathway and systems analysis using proprietary Impact Analysis, and iSCanGuide™ for GPU-accelerated single-cell and spatial transcriptomics. The platform is augmented by complementary tools including iBioGuide (free search engine), iVariantGuide (variant interpretation), and iKnowledgeBase (curated database). The architecture integrates these tools—iSCanGuide connects to iPathwayGuide to extend analysis from raw transcriptomics to biological interpretation—unified through cloud-based delivery requiring no local installation.

Differentiator

Problem solved

Functional benefit

Brands

  • iPathwayGuide: Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for pathway analysis, gene ontology analysis, disease analysis, and upstream regulator analysis.
  • iSCanGuide
  • iBioGuide
  • iVariantGuide
  • iKnowledgeBase

Products and services

  • iPathwayGuide Multi-omics pathway and systems analysis platform using proprietary Impact Analysis methodology for transcriptomics, proteomics, epigenomics, and methylomics data interpretation. Supports human, mouse, and rat organisms and provides gene ontology analysis, pathway analysis, predicted miRNA analysis, disease analysis, and drug response predictions. Used by academic researchers, core facilities, and pharma research teams.
  • iSCanGuide GPU-optimized cloud platform for large-scale single-cell and spatial transcriptomics analysis with no-code GUI interface, standardized reproducible workflows, support for 10x Genomics Visium and Xenium formats, and integrated cell-to-cell communication analysis. Designed for researchers working with high-throughput single-cell and spatial datasets.
  • iBioGuide Free browser-based search tool built on Advaita's knowledge base of over 100 million biological relationships. Allows users to search for genes, microRNAs, pathways, biological processes, molecular functions, cellular components, drugs, diseases, and references. No email required to use.
  • iVariantGuide Variant analysis and interpretation platform that takes VCF files, annotates them with multiple sources, and provides interactive filters for exploring relationships between biological features and effects. Includes advanced pruning algorithms for eliminating false positives in GO analysis. Accessible via API for batch processing.
  • iKnowledgeBase Curated research knowledge base containing integrated databases for genes, pathways, diseases, drugs, microRNAs, GO terms, and molecular interactions, updated weekly with 20+ integrated sources plus a proprietary layer.

Quantifiable outcome

  • Analysis completed in ~15 minutes versus potentially days of manual work
  • +2 more outcomes

Companies that use Advaita

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Advaita technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Advaita partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered regional and core.

  • Inqaba Biotechnical IndustriesregionalChannel Partner/ Reseller/ Distributor · 14 October 2019Distribution partnership providing advanced pathway analysis software access to researchers in Sub-Saharan Africa. Inqaba Biotechnical Industries serves as the authorized distributor for the region.
  • SCIEXcoreStrategic or Co-development PartnerCollaboration enabling users to bring SWATH proteomics data from SCIEX workflow and analyze it in the context of pathways, gene ontologies, microRNAs, and diseases within iPathwayGuide. Combines protein expression experiments with RNA-Seq, microarrays, and targeted panels.
  • Wayne State UniversitycoreStrategic or Co-development PartnerAcademic origin of the technology. Dr. Sorin Draghici developed the Impact Analysis method at Wayne State University's Intelligent Systems and Bioinformatics Laboratory. Ongoing academic affiliation with Dr. Draghici serving as Professor of Computer Science and Obstetrics and Gynecology.
  • National Science Foundation (NSF)coreStrategic or Co-development PartnerDr. Sorin Draghici serves as Program Director at NSF since July 2022. Represents academic-government partnership and scientific credibility.

Scale indicators6 records

Expansion highlights6 records

Advaita competitors and assessment

Company assessment

Direct peers

  • QIAGEN Digital Insights (Ingenuity Pathway Analysis): QIAGEN's Ingenuity Pathway Analysis (IPA) is the most entrenched commercial pathway and multi-omics interpretation platform, directly competing with iPathwayGuide across transcriptomics, proteomics, and upstream regulator analysis for both academic and pharma customers.
  • Illumina (Partek Flow): Illumina acquired Partek, a genomics/bioinformatics software suite offering pathway and single-cell analysis — a direct competitor in cloud-based omics interpretation, now backed by Illumina's sequencing installed base.
  • Velsera (formerly Seven Bridges): Velsera operates a cloud bioinformatics platform for multi-omics and single-cell analysis with API-accessible workflows, directly comparable to Advaita's cloud-delivered, no-code analysis positioning for cores, CROs, and enterprise teams.
  • DNAnexus: DNAnexus provides a regulated (HIPAA/FedRAMP) cloud bioinformatics platform for omics data processing and analysis, competing with Advaita for translational and pharma enterprise workloads that require compliant, programmatic, multi-omics pipelines.

Emerging players

  • Broad Institute (GSEA / MSigDB): GSEA and the MSigDB molecular signature database are the de facto open-standard pathway and enrichment analysis tooling, competing head-on with iPathwayGuide's enrichment analysis layer and influencing academic purchasing decisions.
  • Rosalind (BioSpecimen / single-cell analysis): Rosalind offers a cloud-based, no-code bioinformatics platform with single-cell and pathway analysis capabilities, competing with iSCanGuide/iPathwayGuide in the no-code, multi-omics experience for academic and translational researchers.
  • Metascape: Metascape is a widely adopted free academic pathway analysis tool with multi-omics support; it competes with iPathwayGuide for academic PIs who might otherwise adopt a paid commercial alternative if pricing pressure exists.

Broad incumbents

  • Benchling: Benchling is a broader cloud R&D platform for life sciences that includes registry, assay, and increasingly informatics workflows — an incumbent adjacent to Advaita that competes for biotech enterprise IT budgets and could expand into omics interpretation.
  • 10x Genomics (Cloud Analysis / Loupe): 10x Genomics bundles proprietary single-cell and spatial analysis software with its instruments; its cloud analysis offerings directly overlap with iSCanGuide for Visium and Xenium users, and 10x's installed base gives it a structural advantage.
  • Dotmatics: Dotmatics provides an end-to-end scientific R&D platform spanning informatics, biology, and chemistry; its biology and omics modules overlap with Advaita's pathway and multi-omics interpretation positioning for pharma R&D.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Advaita social profiles

Digital presence

Advaita compliance and trust

Trust signal

Compliance1 record

Advaita financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Advaita leadership team

Management profile

Number of profiles

Profiles7 records

Advaita funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Advaita M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Advaita

What does Advaita do?

Advaita develops and operates cloud-based bioinformatics analysis platforms that transform multi-omics, single-cell, and spatial transcriptomics datasets into biologically meaningful interpretations. Its flagship products are iPathwayGuide (multi-omics pathway and systems analysis using proprietary Impact Analysis methodology) and iSCanGuide (GPU-accelerated single-cell and spatial transcriptomics analysis), complemented by iBioGuide (free search tool), iVariantGuide (variant interpretation), and iKnowledgeBase (curated research databases). The platforms serve academic researchers, core facilities, CROs, and biotech/pharmaceutical enterprise teams with subscription and per-analysis pricing.

Is Advaita a public or private company?

Advaita is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Advaita founded?

Advaita was founded in 2006. It employs 11 to 50 people.

Where is Advaita based?

Advaita is headquartered in Ann Arbor, United States, in the North America region.

How does Advaita make money?

Three revenue lines are on record. iPathwayGuide Subscriptions are the primary driver. The others are single Analysis Purchase and departmental/Institution-wide Licenses.

Who are Advaita's main competitors?

Direct peers on record are QIAGEN Digital Insights (Ingenuity Pathway Analysis), Illumina (Partek Flow), Velsera (formerly Seven Bridges) and DNAnexus. Emerging players are Broad Institute (GSEA / MSigDB), Rosalind (BioSpecimen / single-cell analysis) and Metascape. Broad incumbents are Benchling, 10x Genomics (Cloud Analysis / Loupe) and Dotmatics.

Does Advaita have an API?

Yes. Advaita offers an API for programmatic access to iPathwayGuide and iVariantGuide. The API enables users to submit analyses programmatically in batch mode, automating workflows that would otherwise require manual configuration. Users can launch multiple comparisons programmatically instead of setting everything up manually, significantly increasing productivity for groups with large analysis volumes. Developer documentation is at apps.advaitabio.com/oauth-provider/login.

What industry is Advaita in?

Advaita's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAdvaita Bio lance iSCanGuide™ : analyse unifiée de la transcriptomique unicellulaire et spatiale, reposant sur une infrastructure optimisée par GPUAdvaita Bio announced the launch of iSCanGuide, a cloud-based GPU-optimized platform designed to transform large-scale spatial and single-cell transcriptomics datasets into biologically actionable results. The platform unifies previously fragmented workflows that required weeks of manual work into a matter of minutes, integrating with the company's flagship iPathwayGuide platform trusted by over 13,000 researchers worldwide. Key features include a no-code GUI interface, standardized workflows for reproducibility, support for major data formats including 10x Genomics Visium and Xenium, and integrated cell-to-cell communication analysis.EIN PresswireBollywood’s Biggest Musical Extravaganza Lights Up the EsplanadeAGP World, in association with Advaita Events, will present the world premiere of the Bollywood musical 'Marry Go Round' at Singapore's Singtel Waterfront Theatre, Esplanade on March 14, 2026. The 120-minute production, directed by Bhavna Pani and starring Vidya Malavade, Mohan Kapur, and Apoorva Arora alongside 26 performers, is being positioned as a blockbuster family entertainer. This marks AGP World's return to the Esplanade following their 2023 staging of 'Devdas - The Musical'.PR NewswireDecoding Human Health: How One Partnership is Bringing Accessibility and Collaboration to Genomic Data AnalysisOnRamp Bioinformatics and Advaita BioInformatics have announced a partnership to integrate their genomic data analysis platforms, ROSALIND and iPathwayGuide, providing researchers with a seamless workflow from raw Next-Gen Sequencing data to comprehensive biological interpretation. The combined solution operates at a $40 per-sample pricing model with ROSALIND offered free to access, aiming to eliminate cost barriers and make multi-omic analysis accessible to scientists without prior bioinformatics experience. Market reports estimate the RNA analysis segment alone will grow to a $3.62B market by 2021, with the partnership positioning both companies to capture demand in this expanding sector.